Kim Kelderman sold $1.0M of TECH
Chief Executive Officer at BIO-TECHNE Corp. 13,392 shares at an average of $77.29, traded Jan 27, 2025, filed Jan 29, 2025.
Score components
- +25RoleCEO
- +25Trade size$1.0M at market
- +10Share of holdings soldSold 26% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -13.9%, 3m -29.8%, 6m -19.4%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001062993-25-001237, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jan 27, 2025 | MOption exercise Common Stock | +13,392 | $37.70 | $505k | 52,396 | Jan 29, 2025 |
| Jan 27, 2025 | SOpen-market sale Common Stock | -11,731 | $77.19 | $906k | 40,665 | Jan 29, 2025 |
| Jan 27, 2025 | SOpen-market sale Common Stock | -1,661 | $77.95 | $129k | 39,004 | Jan 29, 2025 |
| Jan 27, 2025 | MOption exercise Stock Option (Right to Buy)derivative | -13,392 | $0.00 | $0 | 0 | Jan 29, 2025 |
Related signals
Other insiders at BIO-TECHNE Corp and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 34Weak | TECHsell BIO-TECHNE Corp | Amy E. Herr director | $320k 6,636 shares | -97% | |
| 45Moderate | TECHsell BIO-TECHNE Corp | Amy E. Herr director | $117k 1,976 shares | -91% | |
| 42Moderate | BIO-TECHNE Corp | Robert Baumgartner V director | $958k 17,040 shares | -28% | |
| 42Moderate | BIO-TECHNE Corp | Roeland Nusse director | $960k 17,040 shares | -28% | |
| 18Weak | TECHsell BIO-TECHNE Corp | Amy E. Herr director | $64k 1,280 shares | -39% | |
| 20Weak | TECHsell BIO-TECHNE Corp | Amy E. Herr director | $123k 1,860 shares | -48% | |
| 42Moderate | TECHsell BIO-TECHNE Corp | Roeland Nusse director | $801k 10,400 shares | -19% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.